Related Experiment Video
Updated: Jul 20, 2025

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
14.6K
Rates and Causes of Reoperations Following Spinal Cord Stimulation Within a 2-12 year Period
Dimitrios V Papadopoulos1,2, Madeline S Suk1, David Andreychik1
1Department of Orthopaedic Surgery, Geisinger Medical Center, Danville, PA, USA.
Global Spine Journal
|August 5, 2023
Summary
Reoperation after spinal cord stimulation (SCS) occurred in 9.5% of patients, often due to lead issues or lack of pain relief. Optimizing patient selection and SCS device placement can reduce reoperation rates.
Area of Science:
- Neurosurgery
- Pain Management
- Medical Device Technology
Background:
- Spinal cord stimulation (SCS) is a key treatment for persistent postsurgical neuropathic pain.
- Reoperation is a significant concern following SCS implantation.
- Understanding reoperation rates and causes is crucial for improving patient outcomes.
Purpose of the Study:
- To determine the rate and reasons for reoperation after spinal cord stimulation.
- To identify risk factors associated with reoperation and surgical site infections.
Main Methods:
- A retrospective study analyzed data from patients who underwent SCS implantation over a 10-year period.
- Medical records were reviewed to identify reoperations, demographics, and clinical parameters.
- Statistical analysis compared patient groups with and without reoperations or infections.
Main Results:
- The overall reoperation rate was 9.5% (97 out of 1014 index procedures).
- Lead migration/misplacement (3.0%) and lack of pain relief (3.1%) were primary causes for revision.
- Younger age correlated with reoperation risk, while higher BMI and diabetes increased infection risk.
Conclusions:
- Strategies like precise SCS lead placement and improved generator design could lower reoperation rates.
- Preoperative patient optimization may reduce complications and enhance clinical outcomes.
- Addressing identified risk factors can improve the overall success of SCS therapy.

